Sheryl L. Conley's most recent trade in Anika Therapeutics Inc. was a trade of 14,164 Common Stock done . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anika Therapeutics Inc. | Sheryl L. Conley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 14,164 | 42,568 (0%) | 0% | 0 | Common Stock | |
| Neuronetics Inc | Sheryl L. Conley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 30,000 | 214,390 (1%) | 0% | - | Common Stock | |
| Neuronetics Inc | Sheryl L. Conley | Director | Other type of transaction at price $ 2.25 per share. | 07 Feb 2025 | 44,444 | 184,390 (0%) | 0% | 2.3 | 99,999 | Common Stock |
| Anika Therapeutics Inc. | Sheryl L. Conley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2024 | 5,771 | 28,404 (0%) | 0% | 0 | Common Stock | |
| Neuronetics Inc | Sheryl L. Conley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2024 | 25,000 | 139,946 (0%) | 0% | - | Common Stock | |
| Anika Therapeutics Inc. | Sheryl L. Conley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 6,500 | 22,633 (0%) | 0% | 0 | Common Stock | |
| Neuronetics Inc | Sheryl L. Conley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 36,364 | 114,946 (0%) | 0% | - | Common Stock | |
| Anika Therapeutics Inc. | Sheryl L. Conley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 7,954 | 16,133 (0%) | 0% | 0 | Common Stock | |
| Neuronetics Inc | Sheryl L. Conley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 38,910 | 78,582 (0%) | 0% | - | Common Stock | |
| Neuronetics Inc | Sheryl L. Conley | Director | Sale of securities on an exchange or to another person at price $ 14.03 per share. | 01 Jun 2021 | 6,200 | 39,672 (0%) | 0% | 14.0 | 87,005 | Common Stock |
| Neuronetics Inc | Sheryl L. Conley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 7,137 | 52,672 (0%) | 0% | - | Common Stock | |
| Neuronetics Inc | Sheryl L. Conley | Director | Sale of securities on an exchange or to another person at price $ 13.78 per share. | 27 May 2021 | 6,800 | 45,872 (0%) | 0% | 13.8 | 93,684 | Common Stock |